Cargando…
SUN-LB23 Translational Feasibility of Steroidogenic Factor-1 Antagonists as a Novel Targeted Therapy for Adrenocortical Cancer
Adrenocortical carcinoma (ACC) is an aggressive cancer with devastating outcomes. ACC is usually locally advanced or metastatic at diagnosis and, despite tumor resection plus chemotherapy, has a high rate of recurrence. The 5-year survival rate among metastatic ACC patients is less than 15%. ACC res...
Autores principales: | Crowe, Paul D, Tao, Haiyan, Fox, Ray, Raheja, Neil, Thacher, Scott McNear |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209441/ http://dx.doi.org/10.1210/jendso/bvaa046.2180 |
Ejemplares similares
-
RF07 | PSUN355 Downstream Targets of the Steroidogenic Factor-1 (SF-1) Antagonist OR-449 in PDX Models of ACC
por: Crowe, Paul, et al.
Publicado: (2022) -
SUN-LB22 PLK1 as a New Treatment Target for Adrenocortical Carcinoma
por: Smith, Gabrielle, et al.
Publicado: (2020) -
SAT-LB23 Paraneoplastic Hypercalcemia in a PTH Producing Adrenocortical Carcinoma - a Rare and Deadly Condition
por: Gruber, Sven, et al.
Publicado: (2020) -
SUN-LB060 Paraganglioma in Pregnancy: Challenges to Treatment
por: Diamond, Samantha, et al.
Publicado: (2019) -
SUN-LB053 Metabolic Interaction of SAH and SAM in hPheo1 Cells
por: Ghayee, Hans, et al.
Publicado: (2019)